CLLS

NASD Cellectis S.A. Sponsored ADR
Oct 7, 2026 · 7:29 PM ET LAST TRADE Market Closed

$1.35 ↑ +0.01 (+0.75%) Trading Up from the previous close of $1.34, $0.05 below the day’s high of $1.40

YTD change
-72.11%
vs 20-day SMA
-22.11%
vs 200-day SMA
-60.08%

Price ranges

Previous day
$1.37 $1.44
open $1.42 close $1.40
-$0.02 (-1.41%)
Today
$1.33 $1.40
open $1.35 now $1.35
+$0.00 (+0.00%)
Past week
$1.37 $1.53
from $1.47 now $1.35
-$0.12 (-8.16%)
Past month
$1.25 $3.26
from $3.16 now $1.35
-$1.81 (-57.28%)
This year
$1.25 $4.97
from $4.84 now $1.35
-$3.49 (-72.11%)

Price & Performance

-1.96 (-58.33%) / 6M

$1.13$2.31$3.49$4.66Apr 7Jul 8Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 96.5% away from all-time highs of $38.85
  • CLLS is down 72% since the beginning of the year
  • CLLS is down 65% over the past 12 months
  • CLLS is down 57% over the past 1 month
  • 1% of all CLLS investors are betting against CLLS

CLLS reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -63.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.22
Earnings momentum -22.2% Quarterly EPS growth
Quarterly change -22.2%

Valuation

P/E ratio N/A
Enterprise value $78.3M
Beta 4.94

Balance sheet & scale

IncomeN/A
Revenue$56.6M
Cash$166.8M
Debt$104.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $135.9M

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Competitor comparison

TickerCompany PriceChange
CMXHF CSL Limited $127.68 +0.14%
ARGX argenx SE Sponsored ADR $930.52 +1.93%
ONC BeOne Medicines Ltd. Sponsored ADR $362.78 +0.31%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $14.79 +3.43%
INCY Incyte Corporation $112.73 -1.23%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.